Plain-English translation of NCT06962839 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new medication called to see if it can help improve vision in people with a type of diabetic eye swelling called centre-involved diabetic macular edema. The study is split into two parts: first, researchers will compare the medication against a placebo (a pill with no medicine) to see if it works, and then they will test different doses of the treatment to find the right amount.
Diabetic eye swelling can cause vision loss and currently available treatments may not work well enough for everyone. This study is testing whether this new medication could offer a better way to treat this condition.
You likely qualify if…
You likely don't qualify if…
You will take tablets by mouth twice a day for about 11 months as part of either the first or second study phase. You will visit the study site 16 times during the year, where doctors will check your vision, take detailed pictures of your eye, and ask about any health changes. The main goal is to track how the treatment affects your eye swelling and vision over time compared to people receiving placebo.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
United States